Therapeutic equivalence of once- and thrice-daily glipizide
暂无分享，去创建一个
[1] K. Asplund,et al. Glibenclamide-associated hypoglycaemia: A report on 57 cases , 1983, Diabetologia.
[2] A. Melander,et al. Bioavailability, Pharmacokinetics and Effects of Glipizide in Type 2 Diabetics , 1982, Clinical pharmacokinetics.
[3] V. Herbert,et al. Coated charcoal immunoassay of insulin. , 1965, The Journal of clinical endocrinology and metabolism.
[4] T. Kuzuya,et al. Human C-peptide immunoreactivity (CPR) in blood and urine — Evaluation of a radioimmunoassay method and its clinical applications , 1976, Diabetologia.
[5] G. Sartor,et al. Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects , 1980, European Journal of Clinical Pharmacology.
[6] G. Sartor,et al. Impaired effect of sulfonylurea following increased dosage , 2004, European Journal of Clinical Pharmacology.
[7] I. Christenson,et al. The antidiabetic effect and pharmacokinetic properties of glipizide. Comparison of a single dose with divided dose regime. , 2009, Acta medica Scandinavica.
[8] A. Melander,et al. High-performance liquid chromatographic determination of glipizide and some other sulfonylurea drugs in serum. , 1979, Journal of chromatography.